Second Sight Medical (EYES) Reports In-Line Q4 EPS

Second Sight Medical (NASDAQ: EYES) reported Q4 Adj. EPS ex-items of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $715 thousand, versus $2.4 million reported last year.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
• Live Oak Bancshares, Inc. (LOB) Misses Q1 EPS by 11c
• St. Joe Company (JOE) Reports Q1 EPS of $0.24